Onanong Phokaewvarangkul

ORCID: 0000-0003-0060-9935
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Parkinson's Disease Mechanisms and Treatments
  • Neurological disorders and treatments
  • Botulinum Toxin and Related Neurological Disorders
  • Genetic Neurodegenerative Diseases
  • Autism Spectrum Disorder Research
  • Voice and Speech Disorders
  • Neurological and metabolic disorders
  • Dysphagia Assessment and Management
  • Restless Legs Syndrome Research
  • Long-Term Effects of COVID-19
  • Transcranial Magnetic Stimulation Studies
  • Lysosomal Storage Disorders Research
  • Parkinson's Disease and Spinal Disorders
  • Neurological diseases and metabolism
  • RNA regulation and disease
  • Consumer Attitudes and Food Labeling
  • Nutritional Studies and Diet
  • Respiratory and Cough-Related Research
  • Phonocardiography and Auscultation Techniques
  • Mosquito-borne diseases and control
  • Pain Mechanisms and Treatments
  • Hereditary Neurological Disorders
  • Ginkgo biloba and Cashew Applications
  • Cerebral Palsy and Movement Disorders
  • Attention Deficit Hyperactivity Disorder

King Chulalongkorn Memorial Hospital
2018-2025

Thai Red Cross Society
2018-2025

Chulalongkorn University
2018-2025

John Wiley & Sons (United States)
2023

The rising prevalence of Parkinson’s disease (PD) globally presents a significant public health challenge for national healthcare systems, particularly in low-to-middle income countries, such as Thailand, which may have insufficient resources to meet these escalating needs. There are also many undiagnosed cases early-stage PD, period when therapeutic interventions would the most value and least cost. traditional “passive” approach, whereby clinicians wait patients with symptomatic PD seek...

10.3389/fneur.2024.1386608 article EN cc-by Frontiers in Neurology 2024-05-13

Neurological symptoms are common manifestation in acute COVID-19. This includes hyper- and hypokinetic movement disorders. Data on their outcome, however, is limited.Cases with new-onset COVID-19-associated disorders were identified by searching the literature. Authors contacted for outcome data which reviewed analyzed.Movement began 12.6 days average after initial onset of 92% patients required hospital admission (mean duration 23 days). In a fraction (6 27; 22%; 4 males/2 females, mean age...

10.1007/s00415-023-11661-x article EN cc-by Journal of Neurology 2023-03-21

Background ON-freezing of gait (ON-FOG) in Parkinson’s disease (PD), often resistant to medication, is linked sensory deficits and proprioceptive impairment, results falls reduced life quality. While visual cues from a laser cane (LC), which rapidly accesses the motor cortex, are commonly used compensate for increased reliance may be affected by progression. Emerging evidence suggests that modulation peripheral processing alleviate ON-FOG, therapeutic Thai acupressure (TTA) solution. This...

10.3389/fneur.2024.1327448 article EN cc-by Frontiers in Neurology 2024-01-29

Background/Objectives: Respiratory diseases are common and result in high mortality, especially the elderly, with pneumonia chronic obstructive pulmonary disease (COPD). Auscultation of lung sounds using a stethoscope is crucial method for diagnosis, but it may require specialized training involvement pulmonologists. This study aims to assist medical professionals who non-pulmonologist doctors early screening COPD by developing smart cloud server-embedded machine learning diagnose sounds....

10.3390/biomedicines13020354 article EN cc-by Biomedicines 2025-02-04

Parkinson’s disease (PD) is associated with dysfunction of monoamine neurotransmitter systems. We investigated changes in the levels and their metabolites PD patients, together association to clinical profiles. patients age-matched control subjects ( n = 40 per group) were enrolled. Using high-performance liquid chromatography (HPLC) an electrochemical detector, monoamines (dopamine, DA; norepinephrine, NE; epinephrine, EPI; serotonin, 5-HT) measured plasma, while (homovanillic acid, HVA;...

10.3389/fnins.2021.605887 article EN cc-by Frontiers in Neuroscience 2021-07-29

Abstract Background No clinical trials have been specifically designed to compare medical treatments after surgery in Parkinson's disease (PD). Objective Study's objective was the efficacy and safety of levodopa versus dopamine agonist monotherapy deep brain stimulation (DBS) PD. Methods Thirty‐five surgical candidates were randomly assigned receive postoperative with either or a randomized, single‐blind study. All patients reevaluated short‐ (3 months), mid‐ (6 long‐term (2.5 years)...

10.1002/mds.28382 article EN cc-by Movement Disorders 2020-11-09

A retrospective analysis at 2 specialist centers was undertaken to determine the long-term efficacy of subcutaneous apomorphine infusion (APO), rates and reasons for discontinuation, factors that might contribute discontinuation.Demographics, clinical outcomes data, discontinuation were collected patients treated with APO Chulalongkorn Centre Excellence Parkinson's Disease Related Disorders, Bangkok, Thailand (n = 36) Fundacion Jimemez Diaz Universidad Autonoma de Madrid, Spain 16).There 19...

10.1097/wnf.0000000000000361 article EN Clinical Neuropharmacology 2019-09-01

Despite our ageing populations, elderly patients are underrepresented in clinical research, and research is often separate from that of Parkinson's disease (PD). To knowledge, no previous study has focused on the most ('old-old', age ≥ 85 years) with PD to reveal how directly influences progression.We compared characteristics pharmacological profiles, including complications levodopa treatment, progression, disabilities, comorbidities old-old those comparable younger ('young-old', 60-75...

10.1371/journal.pone.0261302 article EN cc-by PLoS ONE 2021-12-22

People with Parkinson's (PwP) often feel stigmatized, especially when their symptoms are visually prominent. In some countries, public awareness of disease can be minimal, leading to social challenges for PwP.A educational campaign using videos (VDO) showing 5 PwP in different situations that could a source inconvenience others were launched on Facebook (FB) and television (TV). We describe the process report impact patients public. Number shares likes first 100 comments FB analyzed.There...

10.2147/prom.s243990 article EN cc-by-nc Patient Related Outcome Measures 2020-08-01

The concerns of people with Parkinson's disease (PD) about their are often different from the objective clinical picture and subject to various influencing factors, including progression. Currently our understanding these is limited, particularly in Asian countries.A 50-item survey on Disease Patients' Concerns (PDPC Survey) was developed by a multidisciplinary care team. subjective greatest (most commonly concerning symptoms) patients at specialist centre Bangkok, Thailand, were explored...

10.1371/journal.pone.0243051 article EN cc-by PLoS ONE 2020-12-02
Coming Soon ...